Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. | J Hepatol;34(2): 261-9, 2001 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.

Berson, A; Fau, D; Fornacciari, R; Degove-Goddard, P; Sutton, A; Descatoire, V; Haouzi, D; Lettéron, P; Moreau, A; Feldmann, G; Pessayre, D.

Affiliation

Berson A; INSERM U481 and Centre de Recherche sur les Hépatites Virales de l'Association Claude Bernard, H pital Beaujon, Clichy, France.

J Hepatol ; 34(2): 261-9, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11281555

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Aryl Hydrocarbon Hydroxylases / Liver / Narcotics Limits: Animals Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Aryl Hydrocarbon Hydroxylases / Liver / Narcotics Limits: Animals Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2001 Document type: Article Affiliation country: Country of publication: